Wantai Sars-Cov2 Total Antibody Elisa

SARS-CoV2-N-Antibody

E10-10032-1 N/A
EUR 276.5
Description: N/A

Antibody Elisa Laboratories manufactures the wantai sars-cov2 total antibody elisa reagents distributed by Genprice. The Wantai Sars-Cov2 Total Antibody Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact antibody elisa. Other Wantai products are available in stock. Specificity: Wantai Category: Sars-Cov2 Group: Total Antibody

SARS-Cov2-Neutralizing-Antibody(Spike)

N/A
EUR 444.44
Description: N/A

SARS-Cov2-Neutralizing-Antibody(Spike)

N/A
EUR 1777.78
Description: N/A

SARS-CoV2 N Protein

100 ug
EUR 395

SARS-CoV2 FL Spike Protein

100 ug
EUR 395

Human anti-SARS-CoV2(N) IgM ELISA Kit

48T
EUR 400.4

Human anti-SARS-CoV2(N) IgM ELISA Kit

5x96T
EUR 2717

Human anti-SARS-CoV2(N) IgM ELISA Kit

96T
EUR 572

Total Antibody information

SARS-Cov2-Neutralizing-Antibody(Spike)

E28F03095-1mg N/A
EUR 1777.78
Description: N/A

GENLISA SARS-CoV-2 (Covid-19) Mu Neutralizing Antibody (B.1.621) ELISA

KBVH490 1 x 96 wells
EUR 665.5

Anti-SARS-CoV-2 Total Antibody Titer Serologic Assay kit (Spike RBD)

RAS-T009 96tests
EUR 631.3
Description: It's been reported that coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Total Antibody to Hepatitis E Virus, HEV-Ab ELISA Kit

DEIA076 96T
EUR 1026
Description: This HEV-Ab ELISA kit is an enzyme linked-immunosorbent assay for in vitro qualitative detection of total antibodies (IgG, IgM, etc.) to hepatitis E virus in humanor animal serum or plasma. It is intended to be used as an aid in supplementary diagnosis to hepatitis E infection, prevalence studies among populations as well as in zoonosis related research on hepatitis E virus.

Total Antibody to Hepatitis G Virus, HGV-Ab ELISA Kit

DEIA078 96T
EUR 1026
Description: The kit is anenzyme-linked immunosorbent assay (ELISA) for qualitative determination of antibodies to hepatitis G virus (anti-HGV) in human serum or plasma. It is intended for use in clinical laboratories for diagnosis and management of patients related to infection with hepatitis G virus.

GENLISA SARS-CoV-2 (Covid-19) Iota Neutralizing Antibody (B.1.526) ELISA

KBVH460 1 x 96 wells
EUR 665.5

SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] 100 ul

BSV-COV-AB-02 100 ul Ask for price
Description: SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] (Spike (S2), Monoclonal)

GENLISA SARS-CoV-2 (Covid-19) Kappa Neutralizing Antibody (B.1.617.2) ELISA

KBVH470 1 x 96 wells
EUR 665.5

GENLISA SARS-CoV-2 (Covid-19) Alpha Neutralizing Antibody (B.1.1.7) ELISA

KBVH410 1 x 96 wells
EUR 665.5

GENLISA SARS-CoV-2 (Covid-19) Lambda Neutralizing Antibody (C.37) ELISA

KBVH480 1 x 96 wells
EUR 665.5

GENLISA SARS-CoV-2 (Covid-19) Omicron Neutralizing Antibody (B.1.1.529) ELISA

KBVH520 1 x 96 wells
EUR 665.5

total AKT Antibody

E2200323 100ug
EUR 225
Description: Available in various conjugation types.

total AKT Antibody

E2200323-3B11 100ug
EUR 225
Description: Available in various conjugation types.

Anti-SARS-CoV-2 (B.1.1.529) Total Antibody Titer Serologic Assay Kit (Spike RBD)

RAS-T069 96tests
EUR 706.2
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure antibodies against the mutants is in urgent need.

Human T-lymphotropicvirusⅠ/II(HTLV-1/2) total antibody Elisa Kit

EK714306 96 Wells
EUR 0.44

SARS-CoV-2 (COVID-19) NSP7 Antibody

9155-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

SARS-CoV-2 (COVID-19) NSP7 Antibody

9155-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.